We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

217 hedge funds and large institutions have $1.48B invested in Immunogen Inc in 2021 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 72 increasing their positions, 71 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% more call options, than puts

Call options by funds: $7.1M | Put options by funds: $3.56M

32% more capital invested

Capital invested by funds: $1.12B → $1.48B (+$359M)

27% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 26

3% more funds holding

Funds holding: 211 → 217 (+6)

1% more repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 71

Holders
217
Holders Change
+6
Holders Change %
+2.84%
% of All Funds
3.81%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
33
Increased
72
Reduced
71
Closed
26
Calls
$7.1M
Puts
$3.56M
Net Calls
+$3.54M
Net Calls Change
+$3.72M

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$53.7M
2
Ameriprise
Ameriprise
Minnesota
+$30.5M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$16.5M
4
CLOS
Compagnie Lombard Odier SCmA
Switzerland
+$15.1M
5
LOAMS
Lombard Odier Asset Management (Switzerland)
Switzerland
+$15.1M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$25.2M
2
CCM
Consonance Capital Management
New York
-$23M
3
Renaissance Technologies
Renaissance Technologies
New York
-$19.4M
4
MWNA
Marshall Wace North America
New York
-$12.6M
5
Citadel Advisors
Citadel Advisors
Florida
-$12.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jacobs Levy Equity Management
101
Jacobs Levy Equity Management
New Jersey
$352K -$2.4M -293,429 -87%
Fisher Asset Management
102
Fisher Asset Management
Washington
$340K +$12.1K +1,487 +4%
JF
103
Jump Financial
Illinois
$339K +$342K +41,890 New
VEA
104
Virtus ETF Advisers
New York
$335K +$5.91K +724 +2%
Natixis Advisors
105
Natixis Advisors
Massachusetts
$331K -$58.2K -7,126 -15%
TI
106
Trexquant Investment
Connecticut
$321K -$360K -44,090 -53%
GC
107
Grace Capital
Massachusetts
$300K -$8.16K -1,000 -3%
Legal & General Group
108
Legal & General Group
United Kingdom
$300K +$31.7K +3,884 +12%
Credit Agricole
109
Credit Agricole
France
$294K +$147K +18,000 +98%
CSS
110
Cubist Systematic Strategies
Connecticut
$293K -$1.25M -153,099 -81%
DT
111
Diversified Trust
Tennessee
$290K -$45.3K -5,553 -13%
Public Employees Retirement Association of Colorado
112
Public Employees Retirement Association of Colorado
Colorado
$283K – – –
NFC
113
Northeast Financial Consultants
Connecticut
$278K – – –
LPL Financial
114
LPL Financial
California
$267K +$2.73K +335 +1%
MWNA
115
Marshall Wace North America
New York
$264K -$12.6M -1,542,169 -98%
Zurich Cantonal Bank
116
Zurich Cantonal Bank
Switzerland
$256K +$109K +13,307 +73%
VAS
117
Vestmark Advisory Solutions
Massachusetts
$252K +$132K +16,155 +108%
Victory Capital Management
118
Victory Capital Management
Texas
$244K +$7.8K +955 +3%
KAS
119
Kestra Advisory Services
Texas
$227K +$228K +27,978 New
JCM
120
Jacobi Capital Management
Pennsylvania
$223K – – –
AC
121
Athanor Capital
New York
$220K -$19.8K -2,429 -8%
RJFSA
122
Raymond James Financial Services Advisors
Florida
$218K -$18.5K -2,269 -8%
BAM
123
Blueshift Asset Management
New Jersey
$216K +$218K +26,640 New
CPIG
124
Chicago Partners Investment Group
Illinois
$199K +$200K +24,477 New
BRWA
125
B. Riley Wealth Advisors
Florida
$197K +$22.7K +2,776 +12%
3 4
5
6 7

IMGN Hedge Fund Activity: Q1 2021 in Review

217 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2021, worth a combined $1.48B — up 32% from $1.12B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new IMGN positions and 26 closed out — a net gain of 7 holders — while 72 added to existing stakes and 71 trimmed.

The largest buyer was OrbiMed, adding an estimated $53.7M. The largest seller was Wellington Management Group, cutting an estimated $25.2M.

  • 217 institutional investors held Immunogen Inc (IMGN) as of Q1 2021, up from 211 in Q4 2020.
  • Funds reported $1.48B of Immunogen Inc stock for Q1 2021, up 32% quarter-over-quarter.
  • 33 funds opened new Immunogen Inc positions in Q1 2021 and 26 closed out, a net change of +7 holders.
  • The largest Immunogen Inc buyer in Q1 2021 was OrbiMed, an estimated $53.7M added.
  • The largest Immunogen Inc seller in Q1 2021 was Wellington Management Group, an estimated $25.2M sold.

Based on aggregated 13F filings for Q1 2021.